<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 177 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page176.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=177">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 177 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 177</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=177"><img src="../thumb/177.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>144 / 2020-04                                                        Blood and Haemopoeitic - 8.6
   NaCl/5% gluc.sol.are the only recomm.dil.for infus. Admin.test dos.  Correct.phase: 50 IU/kg 3x/wk. Adjust dos.when necess.in increm.  dysgeus., skin reacts., back/chest pain, myalg., arthralg., loc.reacts.,
   of 25 mg to new pt bef.1  therapeut.dos. If no adverse react. occurs   of 25 IU/kg 3x/wk.at 4 wkly.interv.until target haemoglob.respons.of   pyrex., fatig., rigors, malaise, periph. oed., liv. enzym.incr.
             st
   aft.60 mins.admin.bal.of init.dos.  10-12 g/dL (6.2-7.5 mmol/L) achiev.  Special precautions: Cross.placenta barrier, discont.ther.in case
   Tot.cumulativ.dos.determ.by Hb lev.& bm. Indiv. dos. & dos.sched.   Maint.phase: Usual dos.to maint.target Hb values betw.17-33 IU/  of paraven.leak., sod.contr. diet, resuscitat.facilit.to be avail.in case
   See prod.lit.for dos.calc.& dilut.criteria.  kg 3x/wk. Max: 200 IU/kg 3x/wk.  of poss. anaphylact. reacts., avoid in hepat.dysfunct.esp. in porphyr.
   IV drip infus./IV inject: Normal recomm.dos. sched. is 100-200 mg   Ca pts.receiv.chemother: Admin.SC. Do not exceed target Hb of   cutan.tarda, monit.Fe status, discont. if signific.clinic.liv.enzym.chang.
   2-3x/wk.depend.on Hb lev. Always allow 15 min.interv.aft.first 25 mg   up to 12 g/dL (7,5 mmol/l) Contin.1 mnth aft.end of chemother.but re-  occur/ongo. bacteraem., ac./chron.infect., asthma, eczema, atop. al-
   of each dos. to check for poss.advers.reacts. If no adverse react.oc-  eval.periodic. Init.dos: 150 IU/kg SC 3x/wk.or 40 000 IU once wkly. If   lerg., do not mix.with other prod.
   curs dur.this time admin.bal.of init.dos.  Hb incr.by at least 1 g/dL (0.6 mmol/l), aft.4 wks.treatm.dos to remain   Drug interactions: Reduc.oral Fe absorpt.if giv. concom.
   Tot.dos.infus: Has been assoc.with incr.incid.of advers. reacts.partic.  unchang. If Hb not incr.by &gt; 1 g/dL (0.6 mmol/l) aft.4 wks.at init.dos.  See also MDR page 705.
   delay.hypersens.theref. restrict to hosp.use only.  incr.dos.to 300 IU/kg 3x/wk. or 60 000 IU wkly.in absence of red cell   FERRIMED, Takeda [P/S]
   Add.tot.amnt.calc.(upto 20 mg/kg bm)to 500 ml dil. & infus.IV over   transfus. If Hb incr.by at least 1 g/dL aft.4 wks.addit.treatm.at incr.
   4-6 hrs. First 25 mg to be infus. over 15 mins.& remain.port.only to be   dos.keep dos.unchang. If Hb not incr.aft.4 wks.addit.treatm.at incr.  Iron (III)-hydroxide polymaltose complex equiv.to iron (Fe)
                                                              Indications: Iron defic.and iron defic.anaem.
   giv.if no advers. reacts.occur. Incr.infus.rate progress.to 45-60 drps/  dos.discont.treatm.as respons.unlikely.
   min. Observ.pt.for at least 1 hr.aft. complet.  Dos adjustm: Avoid rise in Hb great.than 1 g/dL (0,6 mmol/l)/2   (S1) SYRUP, [P/S] H842. 50 mg element.Fe/5 ml.
   IMI: Calc.tot.amnt. Admin.test dos.1 . Admin.as undil. deep IMI   wks.or 2 g/dL (1.25 mmol/l)/mnth.or Hb lev.great.than 12 g/dL (&gt;   725935-006: 100 ml, R171,82
                   st
   of upto 100 mg dly.in the case of act. pts.or 1-2x/wk for inact./  7,5 mmol/l). If Hb is rising at these lev.or approach.12 g/dL reduc.  Dosage: Adults: Take in 2-3 div.dos.with meals. Init. 2,5-5 ml dly.
   bedridden pts.               dos. by 25-50% depend.on rise. If Hb exceeds 12 g/dL (7,5 mmol/l)   incr.by 2,5-5 ml increments to 20 ml dly. Childr: 6-12 yrs: 2,5-12,5 ml/
   Contraindications: Non-Fe defic.anaem.(e.g. haemolyt. anaem.),   withhold ther.until it falls bel.12 g/dL (7,5 mmol/l) then re-init.ther.at   day in 1-2 div.dos. with meals. 2-5 yrs: 1,5-5 ml/day in 1-2 div. dos.
   Fe overload/Fe utilisat. disturbs. (e.g.haemochromatos, haemosi-  dos.25% below prev.dos.  with meals. Infts: 6 mnths-2 yrs:. Up to 6 mg element.Fe/kg bm/
                                                              day in 3-4 div.dos.with feeds. Infts.und.6 mnths: 1-2,5 ml/day in 3-4
   deros.), IV admin. in asthma/ eczema/other atopic allerg. disords.,   Adult surg.pts.in autolog.pre-donat. programme: Admin.IV aft.
   Fe mono-/disaccharide complex.& dextran hypersens., decompens.  complet.of each bld. donat.proced. Mildly anaem.pts. requir.prede-  div.dos.with feeds tak.into acc.any supplem.Fe from formula. Low
                                                              birth weight infts/infts with low Fe store: Init.2 mg/kg bm/day
   liv.cirrhos.& hepatit,. ac/chron.infect., S&S of rheumat.arthrit. act.   posit. of ≥ 4 bld.units: 150-600 IU/kg 2x/wk. x3 wks.prior to surg.
   inflammat., ac.ren.fail., first trimest.of pregn., effic.& safety not do-  Admin.Fe supplementat.throughout course.start as soon as poss.  decr.grad.to 1 mg/kg bm/day.
                                                              (S1) CAPS, [P/S] H840.
   cum.in childr.und.14 yrs.    even sev.wks.prior to init autolog.pre-deposit
   Side effects: Anaphylact.reacts.sometimes as a delay. react., hy-  Adult elect.surg.pts.not participat.in an autolog. pre-donat.  Iron (III)-hydroxide polymaltose complex equiv.to 50 mg element.
                                                              Fe, folic acid 150 µg.
   potens.esp.if admin.to rapid., loss of consciousn., hypertens., alt.  programme: Admin.SC. Recomm.dos.regim: 600 IU/kg wkly x3 wks.
   ment.status, seiz., trem., CNS effs., dysrhythm., tachycard., palpit.,   prior to surg.(days -21, -14, -7) & on day of surg. Where lead time   725927-003: 60, R290,65
   foet. bradycard., dyspn., chest pain, GI disturbs., flush., prurit., rash,   to surg.&lt;3 wks.admin. 300 IU/kg on 10 consecut.days prior to surg,   Dosage: Take in div.dos.with meals.
                                                              Therapeut.dos: 2-4 caps/day.
   angoed., sweat., diaphores., myalg., trem., joint pain in rheumat.  on the day of surg.& 4 days immed.thereaft. 300 IU/kg recomm.for
   arthrit. exacerbat., blurr.vis., feel.hot, cramps, numbn., loc. reacts.,   Hb levels ≤ 13 g/dL (8,1 mmol/l). Stop admin.if Hb reaches 15 g/dl   Supplement.dos: 1-2 caps dly.
                                                              (S1) DS CHEW TABS, [P/S] L/8.3/201.
   haemolys., trans.deafn.      or high.in the pre-op period even if not all dos.given. All to receive
   Warnings and special precautions: Resuscitat. facilit.always to   adeq.iron supplementat.dur.course.& even bef.to achieve high Fe   Iron (III)-hydroxide polymaltose complex equiv.to element.iron. 100 mg.
                                                              726087-009: 30, R290,24
   be avail.for poss.allerg./ anaphylact. reacts., discont.admin.immed.if   stores prior to therapy.
   any signs of anaphylax./hypersens./intol.detect.dur.IV admin., poss.  Contraindications: Antibody-mediat.pure red cell aplasia (PRCA)   Dosage: Chew 1-2 tabs dly.in div.dos.with meals.
                                                              Contraindications: Fe overload (e.g. haemochromatos., haemo-
   type III allerg.react.in auto immune disords. /inflamm.condits., if con-  follow.erythropoietin treatm., uncontr.hypertens., hypersens.to any   sideros., chron. haemolysis /lead induc.anaem) Fe utilisat. disturbs.
   sid.essent.IM admin. prefer.in asthma/allerg.or inflamm.disords., pts.   compon.of these prod., myeloid malign., safety in pregn./lactat. &   (e.g. Thalassaem.or sideroblast.anaem), Fe intol., rep.bld.trans-
   with oth.inflamm.disords.incl LE poss.at incr. risk of delayed reacts,   safety/effic.in childr.not est, surg.pts.who cannot receiv.adeq.anti-  fus., all forms of anaem. with Fe defic. (e.g. megaloblastic anaem.
                           nd
   commence oral Fe ther.5 days aft.last inj., admin.only in 2  & 3 tri-  thrombot.prophylax., sev.coron./periph.arter./carotid/cerebr.vasc.  stemm. from Vit B12 defic.& pernic.anaem), inflamm. condits /malign.
                             rd
   mest.of pregn. if benef.outweighs foet.risk and oral Fe ther. inef-  dis.incl.pts.with recent MI/CVA in pts.sched.for elect. surg.& not on   Side effects: GI irrit.& disturbs., black stools, lassit., headache.
   fect./impractic., poss false.elev.bilirub. ser. val./false.decr.ser.Ca.val.  an autolog.bld.predonat.program.
   Drug interactions: Oral Fe absorpt.reduc.  Side effects: Dos.depend.BP incr./exist.hypertens.aggrav., GI dis-  Special precautions: Use in pregn.& lactat. only aft.consult.physic.
                                                              (S3) INJ, [P/S] H841. 100 mg/2 ml.
   See also MDR page 446.       turbs., headache, flu-like illn., pyrex., rash, ven.& arterial thrombos.,
                                embol., cerebrovasc.accid., TIA’s, hypersens.reacts.incl.anaphylact.  Iron (III)-hydroxide polymaltose complex equiv.to 100 mg element.Fe
   EPREX, Janssen Pharmaceutica &  reacts., hypertens.cris.with encephalopathy, seiz., cerebr.haemorrh.,   Indications: Iron defic.anaem.esp.where inabil. to absorb/toler.adeq.
   Recombinant human erythropoietin (rHuEPO).  arthralg., myalg., porphyr., drug ineffect., periph.oed., loc.reacts.,   amounts of Fe taken oral.
   Indications: Anaem.with chron.ren.fail.in pts.on haemodialys.&   erythropoietin antibody mediat.pure red cell aplas.  725943-017: 5x2 ml, R1 138,32
   periton.dialys., anaem.& reduct.of transfus.requirem.in adult Ca (non-  Special precautions: Monit.concom.cyclospor bld.lev., sudd.mi-  Dosage: Admin. IM only in facilities equip.to treat anaphylax. Test
   myeloid malign.) pts.receiv.chemo-ther.& not due to other fact.such   graine-like headaches, Hb lev.&gt;12 g/dL in chron.ren.fail.assoc.with   dos.of ¼-½ amp.admin.to adults & ½ dly dos in childr.if pt.is new.
   as Fe folate defic./haemolys./GI bleed., incr.yield of autolog.bld.from   high CV event risk, incr.thromboembol.events in Ca pts., uncontrol.  Remain. may be giv. if no advers.eff.aft.at least 30 mins. Dos.indiv.
   pts.in a predonat.programme init.to reduc.risk of expos.to homolog.  hypertens., ischaem.vasc.dis., seiz.hist., suspect.prod.allergy, monit.  accord.to Fe defic. For dos.calculat.& inj.techn.see manuf.prod.lit.
   bld.transfus. Treatm.indicat.in pts.with mod.anaem. (PCV approx.   Hb caref., antibody mediat.pure red cell aplas.when used concom.  Norm.dos: Adults: 1 amp dly.max. 2 amps. Childr: Depend.on bm.
   33-39 % and no Fe defic.) if bld.conserv.proced.not avail./insuff. ei-  with interferon & ribavarin in hepatit.C, determ.anti-erythropoietin   Max. toler.dly.dos: Up to 5 kg: ¼ amp. 5 -10 kg: ½ amp. Pts.weigh.
   ther (a) when sched.maj.elect.surg.req.large vol.of bld.(4+ units bld.  antibod.for poss.PRCA diagnos.if no other caus.detect.for sudd.lack   &gt;10 -45 kg: 1 amp. Recons. diagn.if no respons.aft. 1 -2 wks. Tot.dos.
   for fem./5+ units for mal.) or (b) when period necess.to obt.req.vol.  of effic., maint.Hb not to exceed upper target limit in chron.ren.fail.&   ther. should not exceed calcul.no. of amps.
   of autolog.bld.too short., incr.RBC product.& hasten erythroid recov.  Ca pts., ensure adeq.Fe stores, excl.folic acid & vit.B 12 defic.prior to   Contraindications: IV admin., anaem.other than Fe defic., Fe
   in adult pts.with haemoglob. &gt;10 g/dL to &lt;13 g/dL sched.for elect.  init.ther., poss.incr.heparin dos.dur.dialys., eval.contracept.needs, por-  overl.eg. haemochromatos./ haemosideros., Fe utilisat.disturbs.
   surg.& not on an autolog.predonat.programme.  phyr., eval.risk vs. benef.in Ca pts.at risk of thrombot.vasc.events as   incl. thalassaem., ac.haemolyt.phases, Osler-Rendu-Weber syn-
   (S4) INJ. 29/8.3/0769, 0770, 35/8.3/0415, W/8.3/221, 35/8.3/0036  incr.in these events observ.in Ca pts., rout.vol.replacem.in surg.pts.in   dr., chron.polyarthrit., bronch.asthma, infect. ren.complaints in
   837318-009: 2 000 IU/0,5 ml, 6 x pre-fill.syr., R924,68  autolog.pre-donat. programs with underly.CV dis.follow.phlebotomy   ac.phase, uncontroll. hyperparathyroid., decompens.hepat.cirrhos.,
   820741-019: 4 000 IU/0,4 ml, 6 x pre-fill.syr., R1 849,36  as thrombot.& vasc.events may occur, adeq.anti-thrombot.prophy-  infect. hepatit., first trimest.of pregn., concom. oral Fe preps., childr.
   712391-001: 6 000 IU/0,6 ml, 6 x pre-fill.syr., R2 716,70  lax.in elect.surg., DVT predisposit., ther.not recomm.in perisurg.pts.  und.4 mnths.not recomm.
   839876-009: 10 000 IU/1 ml, 6 x pre-fill.syr., R6 483,19  with baseline Hb &gt;13 g/dL, est.& treat.caus.of anaem.in maj.elect.   Side effects: Allerg.reacts.incl.rare anaphylax., fev., leucocytos.,
   705487-001: 40 000 IU/1 ml, 1x pre-fill syr., R4 097,75  orthopaed.surg.bef.start.treatm., safety & effic.not est.with known.  tachycard., incr.CV complic.in angiocardiopathy pts.
   Dosage: Admin instruct: Admin.by IV or SC inj. When chang.from   seiz.hist./disord or underly.haematolog.dis., hypertens.episod.poss.  Special precautions: Cross.placent.barrier, pass. into breast milk,
   one route of admin.to another use same dos.& monit.Hb wkly.to ad-  more likely to occur with rapid Hb respons., monit.platelet count dur.1   st  init.oral Fe ther.at least 1 wk aft. last IMI, outweigh benef.-risk ratio
   just dos.as reqd.to keep Hb in targ.range. Do not shake as glycoprot.  8 wks., epilep., chron.liv.fail.  in pregn., allerg., ren./hepat.insuff., bronch.asthma pts. with low Fe
   may denatur.render.it inact. Do not admin.as IV infus.or in conjunct.  Drug interactions: Eff.poss.potent.by a concom. haematin.agent   binding &/folic acid defic.at partic. risk of allerg. reacts., ac./chron.
   with other drug sols.        (eg.ferrous sulph.) when a defic. state exists.  infect.pts. with excess. ferritin values.
   IV inj: Admin.over 1-5 mins. Slow inj.poss.benefic.to pts.exper.flu-  See also MDR page 402.  Drug interactions: Reduc.absorpt.with oral Fe preps., incr.syst.
   like sympts. Dialysis pts.bolus inj.may be admin.dur.dialys or admin.  effs.with ACE-inhibits.
   follow.dialysis proced.      FERINJECT, Takeda [P/S] &     FERRO DROPS L, (Litha) Pharmacare [P/S]
   SC inj: Max.vol.of 1 ml at any one inj.site. Div.larg.vols.betw.more   Iron as ferric carboxymaltose  Ferrous lactate equiv.to Fe.
   than one inj.site. Inject.should be giv.in limbs/anter.abdom.wall.  Indications: Fe defic.in adults when oral preps. ineffect./cannot be   Indications: Fe-defic.anaem.treatm.&prophylax. for infts.und. 1 yr.
   Chron.ren.fail.pts: Admin.by IV route pref. May be admin.SC   used & where diagn.confirm.by appropr. investigat.  (SO) LIQ. P/8.3/38. 25 mg/ml.
   where IV access not readily avail. (pts.not yet undergo.dialysis/  (S3) SOL FOR INJ/INFUS, 45/8.3/0948. 50 mg/ml  835072-002: 10 ml, R33,95
   peritoneal dialys).          720107-001: 500 mg, 1x10 ml vial, R2 404,68  Dosage: Prophylact: 0,3-0,6 ml dly.based on 1-2 mg Fe/kg bm.
   Correct.phase: Incr.dose if Hb does not incr.by at least 1 g/dL (0,62   Dosage: Admin.only with 0,9% NaCl as dil.for infus. Cumulat.dos.cal-  Therapeut: 1-2 ml dly in 3 div.dos.based on 5 mg Fe/kg bm.
   mmol/l)/month.               culat: Adeq. cumulat.dos. determ. indiv. & not to be exceed. Norm.bm/  Side effects: GI irrit., vomit., diarrh.
   Maint.phase: Decr.dose by 25 IU/kg/dose to avoid exceed.target   bld. vol. relat.to be assum. when determ.Fe requirem.in overweight
   range of 10-12 g/dL (6.2-7.5 mmol/l). Dose should be reduced when   pts. Dos.express.in mg element.Fe. Admin. test dos.of 20-30 mg di-  MIRCERA, Roche
   haemoglobin approaches 12 g/dL.  lut.Ferinject IV to new pts.bef. 1  therap.dos. Bal.of init.dos.may be   Methoxy polyethylene glycol-epoetin beta.
                                              st
   Adult haemodialys.pts: Treatm.div.into 2 stages.  admin. if no adverse react.occurs within 15  min.  Indications: Anaem.assoc.with chron.kidn.dis.
   Correct.phase: 50 IU/kg 3x/wk. Adjust dos.when necess.in increm.   See prod.lit.for formula to calc.Hb restor.& Fe defic. cumulat.dose. Pts.  (S4) INJ, 43/8.3/0941, 42/8.3/0480, 0481, 0482, 43/8.3/0942,
   25 IU/kg 3x/wk.at 4 wkly.interv.until target haemoglob.respons.of 10-  may cont. requir.ther.at low.dos.necess.to maint. Hb lev.  42/8.3/0483, 0484, 0485, 43/8.3/0943
   12 g/dL (6.2-7.5 mmol/L) achiev.  IV bolus inj: Admin.only dur.haemodialys.into ven. limb.of dialyz: Up   717044-001: 30 µg/0,3 ml, sngl.pre-fill.syr., R726,31
   Maint.phase: Indiv.dos.to maint.Hb values at desir.lev.of 10-12 g/dL   to max.sngl.dos.of 4 ml (200 mg Fe)/day but not more than 3x/wk.  712562-001: 50 µg/0,3 ml, sngl.pre-fill.syr., R1 210,53
   (6.2-7.5 mmol/L). Recomm.tot.wkly.dos.betw.75-300 IU/kg  IV drip infus: May be admin.by IV infus.up to max. sngl.dos.of 20 ml   712563-001: 75 µg/0,3 ml, sngl.pre-fill.syr., R1 815,79
   Adult peritoneal dialys.pts: Treatm.div.into 2 stages.  (1 000 mg Fe) not exceed. 0,3 ml (15 mg Fe)/kg bm or calcul.cumulat.  712564-001: 100 µg/0,3 ml, sngl.pre-fill.syr., R1 835,00
   Correct.phase: 50 IU/kg 2x/wk. Adjust dos.when necess.in increm.   dos. Do not admin 20 ml (1 000 mg Fe) more than 1x/wk.  717045-001: 120 µg/0,3 ml, sngl.pre-fill.syr., R2 905,26
   25 IU/kg 2x/wk.at 4 wkly.interv.until target haemoglob.concentrat.of   Contraindications: Anaem.not caus.by Fe defic. e.g.other micro-  712565-001: 150 µg/0,3 ml, sngl.pre-fill.syr., R3 631,58
   10-12 g/dL (6.2-7.5 mmol/L) achiev.  cyt. anaem., Fe overload/Fe utilisat. disturbs., safety in 1  trimest./  712567-001: 200 µg/0,3 ml, sngl.pre-fill.syr., R3 670,00
                                                        st
   Maint.phase: Usual dos.to maint.target Hb values betw.25-50 IU/  repeat. dos. in pregn./lactat.not est., childr.und.18 yrs.as no stud-  712568-001: 250 µg/0,3 ml, sngl.pre-fill.syr., R3 670,00
   kg 2x/wk in equal inj.       ies, IM/SC route.             717046-001: 360 µg/0,6 ml, sngl.pre-fill.syr., R5 548,25
   Adult pre-dialys.pts.(end stage ren.insuffic.): Treatm.div.into   Side effects: Headache, hypersens.incl.potent. fatal anaphylact.  Dosage: Do not mix with other products. Ster.but unpreserv.prod.
   2 stages.                    reacts., dizzin., paraesthes., hypotens., flush., dyspn., GI disturbs.,   theref.do not admin.more than 1 dos. / pre-fill.syr. Do not shake. Reach</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page176.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page172.html">172</a>&nbsp;&nbsp;&nbsp;<a href="page173.html">173</a>&nbsp;&nbsp;&nbsp;<a href="page174.html">174</a>&nbsp;&nbsp;&nbsp;<a href="page175.html">175</a>&nbsp;&nbsp;&nbsp;<a href="page176.html">176</a>&nbsp;&nbsp;&nbsp;<a href="page177.html">177</a>&nbsp;&nbsp;&nbsp;<a href="page178.html">178</a>&nbsp;&nbsp;&nbsp;<a href="page179.html">179</a>&nbsp;&nbsp;&nbsp;<a href="page180.html">180</a>&nbsp;&nbsp;&nbsp;<a href="page181.html">181</a>&nbsp;&nbsp;&nbsp;<a href="page182.html">182</a>
             </td>
             <td width="35%"><a href="page178.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page178.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
